F Lippi

Summary

Affiliation: University of Pisa
Country: Italy

Publications

  1. ncbi Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH
    F Lippi
    Department of Endocrinology and Metabolism, Section of Endocrinology, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy
    Eur J Endocrinol 144:5-11. 2001
  2. ncbi Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma
    F Pacini
    Department of Endocrinology and Metabolism, University of Pisa, 56124 Pisa, Italy
    J Clin Endocrinol Metab 86:5686-90. 2001
  3. ncbi Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients
    F Pacini
    Department of Endocrinology and Metabolism, Section of Endocrinology, University of Pisa, 56124 Pisa, Italy
    J Clin Endocrinol Metab 86:4092-7. 2001
  4. ncbi Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma
    F Pacini
    Section of Endocrinology, Department of Endocrinology and Metabolism, University of Pisa, 56124 Pisa, Italy
    J Clin Endocrinol Metab 88:3668-73. 2003
  5. ncbi Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy
    E Molinaro
    Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
    Q J Nucl Med Mol Imaging 53:490-502. 2009
  6. ncbi Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): serum thyroglobulin measurement
    F Pacini
    Department of Endocrinology and Metabolism, Universita degli Studi di Pisa, Italy
    J Endocrinol Invest 22:25-9. 1999
  7. ncbi Use of surgical gamma probe for the detection of lymph node metastases in differentiated thyroid cancer
    F Lippi
    Dipartimento di Endocrinologia e Metabolismo, Pisa, Italy
    Tumori 86:367-9. 2000

Detail Information

Publications7

  1. ncbi Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH
    F Lippi
    Department of Endocrinology and Metabolism, Section of Endocrinology, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy
    Eur J Endocrinol 144:5-11. 2001
    ....
  2. ncbi Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma
    F Pacini
    Department of Endocrinology and Metabolism, University of Pisa, 56124 Pisa, Italy
    J Clin Endocrinol Metab 86:5686-90. 2001
    ....
  3. ncbi Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients
    F Pacini
    Department of Endocrinology and Metabolism, Section of Endocrinology, University of Pisa, 56124 Pisa, Italy
    J Clin Endocrinol Metab 86:4092-7. 2001
    ..If positive in the lung, (131)I treatment should be continued up to total remission; surgical treatment should be preferred in patients with node metastases, and no treatment should be used in those with thyroid bed uptake or no uptake...
  4. ncbi Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma
    F Pacini
    Section of Endocrinology, Department of Endocrinology and Metabolism, University of Pisa, 56124 Pisa, Italy
    J Clin Endocrinol Metab 88:3668-73. 2003
    ....
  5. ncbi Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy
    E Molinaro
    Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
    Q J Nucl Med Mol Imaging 53:490-502. 2009
    ..The aim of this review was to recall how the rhTSH has been developed and progressively introduced in the clinical management of DTC patients...
  6. ncbi Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): serum thyroglobulin measurement
    F Pacini
    Department of Endocrinology and Metabolism, Universita degli Studi di Pisa, Italy
    J Endocrinol Invest 22:25-9. 1999
    ..With regulatory approval, rhTSH is likely to gain an important role as a preparative adjunct to serum Tg testing in everyday practice...
  7. ncbi Use of surgical gamma probe for the detection of lymph node metastases in differentiated thyroid cancer
    F Lippi
    Dipartimento di Endocrinologia e Metabolismo, Pisa, Italy
    Tumori 86:367-9. 2000
    ..CONCLUSIONS: We conclude that the use of a gamma probe can be successful in patients with metastatic neck lesions resistant to 131I treatment, particularly in patients with nonpalpable lesions...